telmisartan has been researched along with Hypertriglyceridemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Merk, D; Schubert-Zsilavecz, M | 1 |
| Inoue, T; Node, K | 1 |
2 other study(ies) available for telmisartan and Hypertriglyceridemia
| Article | Year |
|---|---|
[Non-agonist inhibitors of Cdk5-dependent phosphorylation of PPAR as insulin sensitizers in the future?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cyclin-Dependent Kinase 5; Diabetes Mellitus, Type 2; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Peroxisome Proliferator-Activated Receptors; Phosphorylation; Telmisartan | 2012 |
Telmisartan as a metabolic sartan for targeting vascular failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Cholesterol; Glucose; Humans; Hypertriglyceridemia; Metabolic Syndrome; PPAR gamma; Risk Factors; Telmisartan | 2008 |